PIMA526774

TFPI Monoclonal Antibody (OTI5A2), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA526774-Each-of-1 In Stock ₹ 52,376.50

PIMA526774 - Each of 1

₹ 52,376.50

In Stock

Quantity

1

Base Price: ₹ 52,376.50

GST (18%): ₹ 9,427.77

Total Price: ₹ 61,804.27

Antigen

TFPI

Classification

Monoclonal

Concentration

1 mg/mL

Formulation

PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3

Gene Accession No.

P10646

Gene Symbols

TFPI

Immunogen

Human recombinant protein fragment corresponding to amino acids 29-304 of TFPI produced in E.coli

Quantity

100μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1

Applications

Immunohistochemistry (Paraffin), Western Blot

Clone

OTI5A2

Conjugate

Unconjugated

Gene

TFPI

Gene Alias

A630013F22Rik; anti-convertin; AW552122; EPI; Extrinsic pathway inhibitor; LACI; Lipoprotein-associated coagulation inhibitor; OTTHUMP00000163472; OTTHUMP00000205431; TFI; TFPI; TFPI1; Tissue factor pathway inhibitor; tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)

Host Species

Mouse

Purification Method

Affinity Chromatography

Regulatory Status

RUO

Gene ID (Entrez)

7035

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Related Products

Img

Novus Biologicals

NB073537

--

Img

Novus Biologicals

NB073507

--

Img

Novus Biologicals

NB073521

--

Img

Novus Biologicals

NB307031

--

Img

Thermo Scientific

PIMA526683

--

Img

Thermo Scientific

PIMA547297

--

Img

Thermo Scientific

PIPA5110398

--

Img

Thermo Scientific

PIMA535564

--

Description

  • Tissue factor pathway inhibitor (TFPI), also known as lipoprotein-associated coagulation inhibitor, is a protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation
  • TFPI is glycosylated and predominantly found in the vascular endothelium and plasma in both free forms and complexed with plasma lipoproteins
  • The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and μgtimately leads to the formation of a fibrin clot
  • TFPI inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop.